Glenn Telling
Overview
Explore the profile of Glenn Telling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
358
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Camacho M, Telling G, Kong Q, Gambetti P, Notari S
Lab Invest
. 2019 Jun;
99(11):1741-1748.
PMID: 31249376
Prion diseases are transmissible neurological disorders associated with the presence of abnormal, disease-related prion protein (PrP). The detection of PrP in the brain is the only definitive diagnostic evidence of...
12.
Yuan Q, Telling G, Bartelt-Hunt S, Bartz J
J Virol
. 2018 Feb;
92(8).
PMID: 29386284
Chronic wasting disease (CWD) is an emerging prion disease in North America. Recent identification of CWD in wild cervids from Norway raises the concern of the spread of CWD in...
13.
Hannaoui S, Amidian S, Cheng Y, Duque Velasquez C, Dorosh L, Law S, et al.
PLoS Pathog
. 2017 Aug;
13(8):e1006553.
PMID: 28800624
Prion diseases are infectious neurodegenerative disorders of humans and animals caused by misfolded forms of the cellular prion protein PrPC. Prions cause disease by converting PrPC into aggregation-prone PrPSc. Chronic...
14.
Waqas M, Lee H, Kim J, Telling G, Kim J, Kim D, et al.
Mol Cell Biochem
. 2017 Jan;
428(1-2):57-66.
PMID: 28063003
Biological effect of poly-L-arginine (PLR), the linear homopolymer comprised of L-arginine, was investigated to determine the activity of suppressing prions. PLR decreased the level of scrapie prion protein (PrP) in...
15.
16.
Yuan Q, Eckland T, Telling G, Bartz J, Bartelt-Hunt S
PLoS Pathog
. 2015 Feb;
11(2):e1004638.
PMID: 25665187
Prions enter the environment from infected hosts, bind to a wide range of soil and soil minerals, and remain highly infectious. Environmental sources of prions almost certainly contribute to the...
17.
Piccardo P, King D, Telling G, Manson J, Barron R
J Virol
. 2013 Sep;
87(22):12349-56.
PMID: 24027305
Misfolding and aggregation of proteins are common pathogenic mechanisms of a group of diseases called proteinopathies. The formation and spread of proteinaceous lesions within and between individuals were first described...
18.
Michel B, Meyerett-Reid C, Johnson T, Ferguson A, Wyckoff C, Pulford B, et al.
Sci Rep
. 2012 Jun;
2:440.
PMID: 22679554
While prions probably interact with the innate immune system immediately following infection, little is known about this initial confrontation. Here we investigated incunabular events in lymphotropic and intranodal prion trafficking...
19.
Bian J, Napier D, Khaychuck V, Angers R, Graham C, Telling G
J Virol
. 2010 Jun;
84(16):8322-6.
PMID: 20519392
Cell-based measurement of prion infectivity is currently restricted to experimental strains of mouse-adapted scrapie. Having isolated cell cultures with susceptibility to prions from diseased elk, we describe a modification of...
20.
Zou W, Langeveld J, Xiao X, Chen S, McGeer P, Yuan J, et al.
J Biol Chem
. 2010 Mar;
285(18):13874-84.
PMID: 20194495
The epitope of the 3F4 antibody most commonly used in human prion disease diagnosis is believed to consist of residues Met-Lys-His-Met (MKHM) corresponding to human PrP-(109-112). This assumption is based...